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Abstract
Background: The Building on Existing Tools to Improve Chronic Disease Prevention and Screening in Family Practice
(BETTER) trial demonstrated the effectiveness of an approach to chronic disease prevention and screening (CDPS)
through a new skilled role of a ‘prevention practitioner’(PP). The PP has appointments with patients 40–65 years of age
that focus on primary prevention activities and screening of cancer (breast, colorectal, cervical), diabetes and
cardiovascular disease and associated lifestyle factors. There are numerous and occasionally conflicting evidence-based
guidelines for CDPS, and the majority of these guidelines are focused on specific diseases or conditions; however,
primary care providers often attend to patients with multiple conditions. To ensure that high-level evidence guidelines
were used, existing clinical practice guidelines and tools were reviewed and integrated into blended BETTER tool kits.
Building on the results of the BETTER trial, the BETTER tools were updated for implementation of the BETTER 2 program
into participating urban, rural and remote communities across Canada.
Methods: A clinical working group consisting of PPs, clinicians and researchers with support from the Centre for
Effective Practice reviewed the literature to update, revise and adapt the integrated evidence algorithms and tool kits
used in the BETTER trial. These resources are nuanced, based on individual patient risk, values and preferences and are
designed to facilitate decision-making between providers across the target diseases and lifestyle factors included in the
BETTER 2 program. Using the updated BETTER 2 toolkit, clinicians 1) determine which CDPS actions patients are eligible
to receive and 2) develop individualized ‘prevention prescriptions’ with patients through shared decision-making and
motivational interviewing.
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Results: The tools identify the patients’ risks and eligible primary CDPS activities: the patient survey captures the
patient’s health history; the prevention visit form and integrated CDPS care map identify eligible CDPS activities and
facilitate decisions when certain conditions are met; and the ‘bubble diagram’ and ‘prevention prescription’ promote
shared decision-making.
Conclusion: The integrated clinical decision-making tools of BETTER 2 provide resources for clinicians and policymakers
that address patients’ complex care needs beyond single disease approaches and can be adapted to facilitate CDPS in
the urban, rural and remote clinical setting.
Trial registration: The registration number of the original RCT BETTER trial was ISRCTN07170460.
Background
Context
The prevalence of chronic disease is steadily increasing
[1, 2], and primary care is an ideal setting for chronic
disease prevention and screening (CDPS) activities [3–5].
Regrettably, evidence-based tools and strategies for CDPS
are inconsistently applied in the primary care setting, in
part due to the numerous and sometimes conflicting rec-
ommendations and guidelines [6, 7]. Since 45 % of people
have one or more chronic disease [8], primary care pro-
viders need effective strategies that address multiple
conditions. However, guidelines are focused on specific
conditions or risk factors [7, 9], which makes it difficult
for clinicians to address patients’ unique risk profiles.
Thus, a comprehensive evidence-based approach to CDPS
has been ‘lost in translation’ [10] and there is a need to en-
gage end-users including clinicians, researchers and pol-
icymakers in a collaborative process [10] to address this
knowledge to action gap. Furthermore, with the compet-
ing demands on primary care providers there is little time
to address CDPS [11, 12]; hence, a new approach that
bridges the evidence to practice gap in primary care CDPS
is needed.
The Building on Existing Tools to Improve Chronic
Disease Prevention and Screening in Family Practice
(BETTER) trial was a pragmatic two-way factorial cluster
randomized controlled trial conducted in urban primary
care team practices in Alberta and Ontario, Canada [12].
Patients aged 40–65 were invited to participate in the
trial and stratified into groups: 1) general medical pa-
tients and 2) patients with moderate mental illness. The
BETTER tool kit and training provided the ‘prevention
practitioners’ (PP) in the two urban settings with the ne-
cessary tools and resources to evaluate patients for mul-
tiple risks. The tools were aimed to prevent multiple
chronic conditions through a process of shared decision-
making, which provided the patient with an individual-
ized ‘prevention prescription’ that included actionable
CDPS goals (see Fig. 1). The PPs in the BETTER trial
were clinicians (licensed practical nurse, nurse, diet-
ician, nurse practitioner) who worked in the multidis-
ciplinary primary care clinics to develop a comprehensive
approach to evidence-based CDPS within the practice
setting [7, 12, 13].
To bridge the gap between knowledge and practice, a
BETTER trial clinical working group (CWG) was formed
with end-users that included PPs, clinicians and re-
searchers with support from the Centre for Effective
Practice [7]. The CWG identified and harmonized high-
quality clinical practice guidelines and tools for primary
CDPS in adults 40–65 years of age [7, 12], creating the
BETTER tool kit that was implemented in the BETTER
trial. This extensive review also defined the scope of the
BETTER trial; the chronic diseases with the best evi-
dence for primary prevention and screening were identi-
fied and incorporated into the comprehensive approach
to CDPS. The target conditions included in the BETTER
trial were cancer (breast, cervical, and colorectal), car-
diovascular disease, diabetes and their associated lifestyle
factors (smoking, alcohol consumption, diet/nutrition
and physical activity). The BETTER trial demonstrated
the effectiveness of a shared decision-making approach
to CDPS that improved the implementation of clinically
important CDPS activities through the new skilled role
of a ‘prevention practitioner’ in both patient strata [12].
Once the BETTER trial demonstrated that a PP could
improve the implementation of clinically important
CDPS actions in a cost-effective manner [12], further
funding was obtained to broaden the reach to other
jurisdictions including urban, rural and remote commu-
nities in Canada and deepen the impact of the interven-
tion through the Building on Existing Tools to Improve
Chronic Disease Prevention and Screening in Primary
Care (BETTER 2) program [14]. To achieve this goal
and bridge the evidence to practice gap, revisions to the
BETTER trial kit were required in order to update the
evidence and adapt the tools into a format that could be
used in diverse primary care settings including rural and
remote settings and with aboriginal populations. This
process was, in part, informed by feedback received from
the participating clinicians and patients in the BETTER
trial as it indicated that some of the items could be
modified or removed, while others, such as the family
history, could be better formatted to improve data capture.
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We describe here the process of integrated knowledge
translation [15–18] that involved engaging end-users from
the various practice settings (including clinicians and pol-
icymakers) with researchers as equal partners in this
knowledge synthesis and the development of the resulting
BETTER 2 tools.
Purpose
The purpose of this paper is to describe 1) the integrated
process used to adapt and refine the BETTER trial tools
for chronic disease prevention and screening (CDPS) by
the BETTER 2 program and 2) the resultant tools that
were then implemented into various urban, rural, remote
and aboriginal primary care settings by the BETTER 2
program.
Methods/design
The BETTER trial CWG identified and reviewed high-
quality clinical practice guidelines and harmonized them
to standardize the recommendations for implementation
into the BETTER trial [7]. The CWG considered strong
evidence that was linked to a target or health outcome
[7] and created the knowledge products for the PP inter-
vention that were used in the trial [7, 12]. The know-
ledge products were developed from November 2009 to
March 2010 through a structured approach to evidence
integration [7] involving a knowledge to action cycle
(Fig. 2) [7, 10]. This involved engaging the researchers
with end-users and policymakers in a process that in-
cluded knowledge synthesis and harmonization through
a structured evidence review process, and then testing
and applying the tools in the various practice settings
through an iterative plan-do-study-act (PDSA) process.
Findings from the local PDSA activities were then inte-
grated into the tools.
The BETTER 2 CWG was convened in November
2012; this group included end-users, clinicians (family
physicians, registered nurses, nurse practitioners), pol-
icymakers from the new jurisdictions (Northwest Terri-
tories, Newfoundland and Labrador) and researchers
tasked with reviewing and updating the high-quality rec-
ommendations for primary prevention of chronic con-
ditions in patients 40–65 years of age. The chronic
conditions included cardiovascular disease, diabetes and
breast, colorectal, lung and cervical cancer, as well as the
associated lifestyle risk factors (e.g. tobacco use, alcohol
overuse, poor diet and physical inactivity) [7, 12]. A tar-
geted search using the process described in our previous
publication [7] was conducted to identify new resources
meeting any of the following criteria:
1. Date of publication subsequent to 2009;
2. Addressing a gap or special population not
considered in the original BETTER trial search;
Fig. 1 The BETTER 2 chronic disease prevention and screening prevention practitioner intervention
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3. Interventions strongly recommended for application
in practice;
4. Recommendations for patients at higher risk due to
family history;
5. New resources identified through scoping reviews of
provincial and territorial recommendations.
The CWG was divided into teams focusing on the fol-
lowing conditions: breast cancer, cervical cancer, colorec-
tal cancer, skin cancer, lung cancer, cardiovascular disease,
diabetes, alcohol, mental health, lifestyle (tobacco, alcohol,
nutrition and physical activity), obesity (waist circumfer-
ence, BMI) and family history.
Scoping reviews of provincial and territorial recom-
mendations were also conducted to assist with further
tailoring of the tools to comply with the approaches to
CDPS in participating Canadian provincial or territorial
jurisdictions (Alberta, Ontario, Northwest Territories,
Newfoundland and Labrador). For example, a decision
was made to reduce the consumption thresholds recom-
mended in Canada’s low-risk alcohol drinking guidelines
[19] as the Northwest Territories was concerned with
the high rates of colorectal cancer in their jurisdiction
concomitant with heavy drinking [20] and the potential
for increased cancer risk in those exceeding the alcohol
levels recommended by the Canadian Cancer Society
[21, 22]. The CWG concluded that the Canadian guide-
lines were more focused on the risk of developing an al-
cohol use disorder and therefore did not adequately
inform individuals about lower alcohol consumption
levels to reduce the risk for chronic disease such as cancer.
The tools were adapted to focus on informing Canadians
about safer levels of alcohol consumption to prevent
chronic disease, an approach that has since been recom-
mended by the Canadian Cancer Society [22].
The members of the BETTER 2 CWG individual topic
teams met, independently reviewed and critiqued the
new information identified and presented their assess-
ments to the CWG for review by the entire group in
November 2012, December 2012 and January 2013. To
address gaps and build on the previous work, a greater
emphasis was placed on tools that would facilitate family
history assessment, address local disease and risk factor
prevalence and help harness local resources. Following
this, the BETTER tools were updated, reviewed, edited
and tested by various members of the BETTER 2 CWG
to determine if they were useful and appropriate in the
various clinical settings. The review and BETTER 2 tool
kit refinement was completed in January 2013 after
which training sessions were held with CWG members
Fig. 2 Guideline harmonization and implementation plan for the BETTER trial. The evidence integration and implementation process for the
Building on Existing Tools to Improve Chronic Disease Prevention and Screening in Family Practice (BETTER) trial. The triangle in the centre of the
diagram is an extension of the ‘knowledge creation funnel’ in the knowledge-to-action cycle [10]. In our process, there is knowledge synthesis
with each funnel representing existing literature captured in high-quality clinical practice guidelines. This is then contextually integrated for each
patient’s family history and modifiable risk factors. The side bar shows the structured evidence review process of the clinical working group. The
boxes around the circumference of the cycle refer to the steps for implementing the recommendations and tools in both the practice- and
patient-level interventions of the BETTER trial. Note: CVD cardiovascular disease, EMR electronic medical record [7]
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and PPs to implement the updated tools into the various
practice settings.
Results
As a result of the comprehensive work of the BETTER 2
CWG, the tools were updated and adapted to address
CDPS in the various urban, rural, remote and aboriginal
contexts. The following tools were refined for inclusion in
the BETTER 2 tool kit: a patient health survey (Additional
files 1 and 2), a CDPS care map (Additional file 3), a pre-
vention visit form (Additional file 4), the bubble diagrams
(Additional file 5) and the prevention prescription with
goals (Additional file 6). The tool kit can be accessed on
the BETTER website [23]. This toolkit was the foundation
for the comprehensive approach to CDPS implemented in
participating jurisdictions and was further customized for
each practice setting through the identification of local, re-
gional and national resources that could be harnessed to
support patients’ CDPS care plans and lifestyle change
goals.
Using the BETTER tools
The patient survey (Additional files 1 and 2) and preven-
tion visit form (Additional file 4) capture the patient in-
formation and characteristics needed to make CDPS
recommendations. The CDPS care map (Additional file 3),
informed by the aforementioned data collection instru-
ments, is a clinical decision aid that helps the clinician de-
termine which CDPS recommendations the patient is
eligible to receive when certain criteria a met, including
when to refer the patient back to their primary care pro-
vider. The bubble diagrams (Additional file 5) are also in-
structive to both the clinician and patient as to the CDPS
activities a patient is eligible to receive and can be used to
facilitate agenda setting with the patient. The prevention
prescription (Additional file 6) is a document intended for
the patients to take with them when they leave the visit
to help inform them of their prevention and screening
status and guide patients on when, where and how they
will go about improving deficient CDPS recommenda-
tions. Through a shared decision-making process be-
tween the clinician and patient, patients also set specific,
measurable, attainable, realistic, timely (SMART) goals
for their health (Additional file 6), providing the patient
and clinician with a personalized plan geared toward en-
abling patients to achieve their CDPS goals.
Patient survey
The BETTER survey
The BETTER patient health survey (Additional file 1)
provides primary care providers with a tool that captures
the comprehensive patient information required to facili-
tate CDPS and monitor progress including the import-
ant behavioural, environmental and familial risk factors.
This tool comprises validated instruments (Additional
file 2) that can gather detailed information relevant to
CDPS including chronic conditions, previous cancer
screening activities, lifestyle information and risks, per-
ception of general health and depression, family history
of certain medical conditions, food security and demo-
graphic information (age, gender, ethnicity, education,
marital status, income). Much of this information is not
routinely collected or available in the medical record;
yet, this information is required for a clinician to deter-
mine the CDPS actions an individual patient should
focus on.
The BETTER trial survey was refined for use in BETTER
2 based partly on feedback received indicating that the
tool could be streamlined and reformatted to improve
data capture and usability. The original patient health sur-
vey was lengthy, consisting of 88 items [12], and included
an assessment of physical activity using activity recall [24]
and a dietary assessment derived from the MEDFICTS, a
dietary instrument with a focus primarily on fat intake
[25, 26]. After review by the BETTER 2 CWG, it was de-
termined that employment of other validated tools to as-
sess diet and exercise, which had been developed for use
in primary care, could improve the ability to identify those
patients who would benefit from a brief intervention and
track changes over time.
Improvements to the original survey were made to
better capture physical activity assessments including
use of the general practice physical activity questionnaire
(GPPAQ) [27] to determine the patients’ level of activity
in addition to the patients’ self-reported number of mi-
nutes spent on exercise weekly to determine if patients
are achieving a CDPS target of ≥150 min per week of
moderate exercise [28–32]. The GPPAQ is a reliable and
validated tool recommended for the assessment of phys-
ical activity in general practice that is supported by the
United Kingdom National Institute for Health and Care
Excellence (NICE) [27]. This tool assesses the respon-
dent’s level of physical activity both in and outside of
work and can be used by clinicians to inform when an
intervention to increase physical activity would be bene-
ficial as well as to track a patient’s progress over time.
A validated tool for dietary assessment and intervention
in the clinical setting, Starting the Conversation [33], was
added to provide the clinician with insight into patients’
eating behaviours and information on how patients could
improve their diet (e.g. increase fruit and vegetables, de-
crease sweetened beverages, decrease unhealthy snacks).
Alcohol consumption is now captured quantitatively
to determine if patients are drinking within healthy alco-
hol consumption guidelines according to the National
Institute on Alcohol Abuse and Alcoholism’s overview
of alcohol consumption for low-risk drinking [34]. Alco-
hol use disorders are also screened for using the
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validated abbreviated form of the alcohol use disorders
identification test, the AUDIT-C [35–38]. The updated
tools provide clinicians with an approach that educate
patients about healthy alcohol consumption as opposed
to only screening for abuse.
The health survey was reduced from 88 to 69 items to
more efficiently capture information on the important
modifiable lifestyle risk factors (smoking, alcohol con-
sumption, diet/nutrition and physical activity) and in-
cludes assessments of the patient’s readiness to change,
gathering the information required to address these risk
factors [39, 40]. The health survey can take up to 30 min
to complete. It may be completed before the patient’s
prevention visit either independently by the patient or
administered by a health care professional when deemed
appropriate (e.g. literacy, language).
Prevention visit form
The prevention visit form (Additional file 4) is a clinical
tool that captures and structures the information obtained
from the patient’s survey and medical chart required to
identify which prevention activities each patient is (or is
not) eligible to receive. Typically, the clinician will partially
complete this form before the patient visit to identify the
CDPS activities eligible for discussion. Further informa-
tion is collected at the time of the prevention visit includ-
ing a limited physical assessment of the patient to obtain
weight, height, waist circumference and blood pressure.
Before the patient visit, the clinician can enter the patient’s
individual CDPS information on a blank version of the
bubble diagram (Additional file 5) and the first page of the
prevention prescription (Additional file 6).
CDPS care maps
The CDPS care map (Additional file 3) provides primary
care providers with an algorithm of the summarized
CDPS recommendations for primary prevention in 40–
65 year olds for patients with and without diabetes. A
health care provider can use the care map as a
decision-making tool during the prevention visit to de-
termine what actions to take when certain conditions
are met. This includes consideration as to what CDPS
actions a patient is eligible or not eligible to receive,
and when to refer a patient back to their primary care
provider. For some actions, particularly cardiovascular
related CDPS, recommendations depend upon whether
a patient has diabetes or not. Use of the CDPS care
map is facilitated by information gathered from the pa-
tient survey, the prevention visit form and during the
prevention visit. Other tools such as the Framingham
risk stratification and/or a family history risk assess-
ment tool can also be used to provide further informa-
tion about the patient’s risks of diabetes, cardiovascular
disease or cancer.
Bubble diagram
The bubble diagram (Additional file 5) provides a brief
overview of the blended evidence-based CDPS activities
for primary prevention in 40–65 year old male and fe-
male patients. Regular screening intervals and healthy
targets summarized in this tool are meant as a compan-
ion piece to the CDPS care map, which depicts the ap-
propriate care path for patients depending on their level
of risk. Specific patient details can be entered on a blank
version of the bubble diagram and then used as a teach-
ing tool when meeting with patients. The bubble
diagrams can facilitate a motivational interviewing ap-
proach through agenda setting [39]. For example, after
educating the patient about CDPS and while showing
the patient their individualized bubble diagram, the clin-
ician can ask the patient what they want to do to im-
prove their health and begin the work that is finalized in
the prevention prescription (described below). Intrinsic
in the patient-centred approach is the ability of the pa-
tient to opt out of discussing any area that they do not
wish to address. The bubble diagram allows the negoti-
ation of a shared agenda for the prevention visit through
a visual emphasis on the bubbles the patient wants to
address.
The bubble diagram with the evidence overview can
also be used as a visual cue to remind primary care pro-
viders about the CDPS activities to consider when seeing
patients in this age group.
Prevention prescription with goals
The prevention prescription (Additional file 6) includes
a summary of the patient’s CDPS status, target check-in
intervals, referrals or actions to be completed, and any
tools provided or linkages made to clinic or community
resources to aid the patient in their CDPS efforts. The
information on the prevention prescription that does
not require shared decision-making can be partially
completed before the visit and then finalized with input
from the patient at the time of the visit. The goal sheet
facilitates shared decision-making through the develop-
ment of SMART goals including an assessment of confi-
dence addressing action planning and self-efficacy in
patient self-management [41, 42]. The prevention pre-
scription with goals can be provided to the patient as a
summary of their visit and serve as the patient’s person-
alized CDPS plan.
Discussion
The need for a BETTER approach to CDPS
Busy clinicians lack adequate tools and resources to ad-
dress CDPS in the primary care setting since many
guidelines focus on specific conditions [7, 9] and lack
precise recommendations that are clinically applicable
[7]. The BETTER tools bridge the knowledge to action
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gap through a blended approach of actionable items at
every step in the process of CDPS from collecting the
necessary patient information to care maps for primary
care providers and teams [7]. Through engaging the
end-users in the process of developing CDPS tools and
resources and applying the tools into the clinical setting,
the BETTER trial was able to effectively implement
CDPS in the family practice setting through a new
skilled role of ‘prevention practitioner’ (PP) [12]. These
tools and resources further facilitate knowledge uptake
by patients through agenda setting, shared-decision-
making and self-management. The updated tools and re-
sources described in this paper were refined in order to
further facilitate patient assessments, education and
shared decision-making aimed to identify and achieve
the patient’s personalized CDPS goals as well as capture
the information required to evaluate CDPS outcomes for
the BETTER 2 program implementation [14] in urban,
rural, remote and aboriginal settings.
Modifiable lifestyle factors such as smoking, unhealthy
eating, physical inactivity and unhealthy alcohol con-
sumption have a huge impact on chronic disease [43]
and there is a pressing need to address multiple behav-
ioural risk factors in primary care [44]. Although ad-
dressing modifiable lifestyle risk factors can significantly
impact mortality and morbidity [43, 45] few individuals re-
ceive lifestyle counselling, even after a significant illness
such as a cardiovascular event [46, 47]. The updated BET-
TER 2 tools provide clinicians with resources that evaluate
the patient’s multiple lifestyle risks including their readi-
ness to change and can be used to track changes over time.
In addition, these tools facilitate shared decision-making
with patients through agenda setting and identifying spe-
cific goals that encourage self-management [41, 42].
The tools are tailored to be adaptable and can be used
in a number of ways as depicted in Fig. 3. In this way,
multidisciplinary teams or family physicians can decide
how best to apply the tools in their clinical settings. The
updated BETTER approach may be used at the policy
and practice level to target at risk populations and invite
patients to receive an effective individualized CDPS
intervention based on high-level evidence [12] supported
by the BETTER 2 tool kit. Moreover, the tools can be
harmonized and integrated with existing public health
initiatives in various settings. For example, an initiative
involving population or practice level CDPS facilitation
may consider the BETTER approach or integrating some
of the tools to translate population level CDPS activities
to individual at-risk patients. Policymakers may provide
primary care providers with the BETTER tools to better
implement CDPS into practice. Decision makers and pri-
mary care providers may adapt the tools to facilitate
policy and practice integration of CDPS including con-
sistent messages at all levels.
This approach to knowledge integration is not without
its limitations. The tools and resources developed focus
on primary prevention of CDPS in patients aged 40–65;
hence other high-level interventions such as immuniza-
tions, secondary prevention and chronic disease man-
agement are not included. The BETTER tools and
resources were developed with knowledge integration
considered at every step to bridge the research to prac-
tice gap through an implementation plan that engaged
the end-users and applied the developed resources into
the practice setting (Fig. 2). Consequently, the final tools
may not reflect the ‘best’ evidence but the best evidence
that could be applied into the settings engaged. Also,
over time, the various guidelines change, requiring con-
stant updating and revisions to the tools. Furthermore,
the process of knowledge integration is time consuming
and requires organization, expertise and resources to
conduct. The time and resources required to integrate
knowledge into practice settings are not readily available
in a health care system that is designed to focus on acute
medicine and disease management. In addition to devel-
oping clinical practice guidelines, resources should also
be used to develop and refine tools and processes, such
as the BETTER 2 tools that allow guidelines to be more
easily implemented into clinical practice.
The BETTER 2 tools have been implemented and
tested in the various practice settings [14] and the out-
comes will be presented in a future publication. The
BETTER 2 tools can be downloaded for use from the
BETTER website [23]. Presently, the tools have been
paper based which may limit the ability to implement
the PP model into primary care in Canada due to the in-
creased use of electronic medical records in primary care.
Electronic versions of the patient survey and prevention
prescription are currently being developed and will be
tested in primary care settings in Alberta, Newfoundland
and Labrador.
Primary care teams should consider implementing the
PP role to better address CDPS in conjunction with the
primary care provider and thereby share the manage-
ment of chronic disease prevention and screening. In
Canada, prevention and early detection could reduce the
burden of managing acute and chronic conditions. Des-
pite that, there are barriers to CDPS. In many jurisdic-
tions, the fee-for-service system does not remunerate
prevention activities. Also, some settings lack the clinical
resources to address the acute and chronic medical
needs of the community. Hence there is limited capacity
to implement the PP model in settings that do not com-
pensate for this CDPS or that lack clinical resources to
address and manage the acute and chronic conditions.
The process could be implemented in other countries
with heath care systems that have the resources to sup-
port this type of activity.
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Conclusion
The BETTER tools are a first step to structure CDPS in
primary care in a comprehensive, structured, personalized
and evidence-based manner and to improve the applica-
tion of knowledge into practice. The integrated clinical
decision-making tools of BETTER 2 provide a resource
for clinicians and policymakers that address patients’ com-
plex care needs beyond a single disease approach and can
be adapted to facilitate CDPS in various primary care clin-
ical setting in urban, rural and remote communities.
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